A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160 · see citing works

The Molecular Signatures Database Hallmark Gene Set Collection

Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807 · see citing works

The cancer genome atlas pan-cancer analysis project

The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · see citing works

Modeling Survival Data: Extending the Cox Model

Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674 · see citing works

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · see citing works

Defining a Cancer Dependency Map

Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276 · see citing works

TEAD mediates YAP-dependent gene induction and growth control

Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498 · see citing works

Systematic identification of genomic markers of drug sensitivity in cancer cells

Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456 · see citing works

The Hippo Signaling Pathway in Development and Cancer

Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,274 · see citing works

Hippo pathway in organ size control, tissue homeostasis, and cancer

Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206 · see citing works

A Landscape of Pharmacogenomic Interactions in Cancer

Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090 · see citing works

Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand

Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046 · see citing works

DrugBank 4.0: shedding new light on drug metabolism

Law, V., Knox, C., Djoumbou-Feunang, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,995 · see citing works

Mechanisms of Hippo pathway regulation

Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667 · see citing works

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

Raamsdonk, C. D. V., Bezrookove, V., Green, G., Bauer, J. M., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2008) · Nature · doi:10.1038/nature07586 · Cited by 1,621 · see citing works

Mutations in GNA11 in Uveal Melanoma

Raamsdonk, C. D. V., Griewank, K., Crosby, M. B., Garrido, M. C., Vemula, S. S., Wiesner, T., Obenauf, A. C., Wackernagel, W., Green, G., Bouvier, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000584 · Cited by 1,481 · see citing works

G-protein-coupled receptors and cancer

Dorsam, R. T., & Gutkind, J. S. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2069 · Cited by 1,399 · see citing works

FAK in cancer: mechanistic findings and clinical applications

Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381 · see citing works

The emerging roles of YAP and TAZ in cancer

Moroishi, T., Hansen, C. G., & Guan, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3876 · Cited by 1,156 · see citing works

Mechanism of Blebbistatin Inhibition of Myosin II

Kovács, M., Tóth, J. S., Hetényi, C., Málnási‐Csizmadia, A., & Sellers, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405319200 · Cited by 1,022 · see citing works

Protein kinase C and other diacylglycerol effectors in cancer

Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978 · see citing works

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

Robertson, A. G., Shih, J., Yau, C. S. F., Gibb, E. A., Oba, J., Mungall, K. L., Hess, J. M., Uzunangelov, V., Walter, V., Danilova, L., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.003 · Cited by 894 · see citing works

An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules

Basu, A. B., Bodycombe, N. E., Cheah, J. H., Price, E. V., Liu, K., Schaefer, G. I., Ebright, R. Y., Stewart, M. L., Ito, D., Wang, S. Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.003 · Cited by 820 · see citing works

A gp130–Src–YAP module links inflammation to epithelial regeneration

Taniguchi, K., Wu, L.-W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F.-X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., et al. (2015) · Nature · doi:10.1038/nature14228 · Cited by 633 · see citing works

Calcium in tumour metastasis: new roles for known actors

Prevarskaya, N. B., Skryma, R. N., & Шуба, Я. М. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3105 · Cited by 606 · see citing works

Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry

Feng, X., Degese, M. S., Iglesias‐Bartolomé, R., Vaque, J. P., Molinolo, A., Rodrigues, M. W., Zaidi, M. R., Ksander, B. R., Merlino, G. T., Sodhi, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.016 · Cited by 559 · see citing works

The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer

O’Hayre, M., Vázquez‐Prado, J., Kufareva, I., Stawiski, E. W., Handel, T. M., Seshagiri, S., & Gutkind, J. S. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3521 · Cited by 559 · see citing works

Protein kinase C: poised to signal

Newton, A. C. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00477.2009 · Cited by 520 · see citing works

The Cyclic AMP PathwayPreprint

Sassone‐Corsi, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011148 · Cited by 519 · see citing works

Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP

Yu, F., Luo, J., Mo, J., Liu, G., Kim, Y. C., Meng, Z., Zhao, L., Peyman, G. A., Ouyang, H. W., Jiang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.017 · Cited by 464 · see citing works

Mitogenic signaling pathways induced by G protein‐coupled receptors

Rozengurt, E. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21246 · Cited by 461 · see citing works

Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance

Marcotte, R., Sayad, A., Brown, K. R., Sanchez-Garcia, F., Reimand, J., Haider, M., Virtanen, C., Bradner, J. E., Bader, G. D., Mills, G. B., et al. (2016) · Cell · doi:10.1016/j.cell.2015.11.062 · Cited by 439 · see citing works

Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma

Carvajal, R. D., Sosman, J. A., Quevedo, J. F., Milhem, M. M., Joshua, A. M., Kudchadkar, R. R., Linette, G. P., Gajewski, T. F., Lutzky, J., Lawson, D. H., et al. (2014) · JAMA · doi:10.1001/jama.2014.6096 · Cited by 433 · see citing works

Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

Cheung, H. W., Cowley, G. S., Weir, B. A., Boehm, J. S., Rusin, S., Scott, J. A., East, A., Ali, L. D., Lizotte, P. H., Wong, T. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109363108 · Cited by 423 · see citing works

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

Cowley, G., Weir, B., Vazquez, F., Tamayo, P., Scott, J. A., Rusin, S., East-Seletsky, A., Ali, L., Gerath, W. F. J., Pantel, S., et al. (2014) · Scientific Data · doi:10.1038/sdata.2014.35 · Cited by 398 · see citing works

The experimental power of FR900359 to study Gq-regulated biological processes

Schrage, R., Schmitz, A.-L., Gaffal, E., Annala, S., Kehraus, S., Wenzel, D., Büllesbach, K. M., Bald, T., Inoue, A., Shinjo, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms10156 · Cited by 366 · see citing works

Use and properties of ROCK-specific inhibitor Y-27632

Narumiya, S., Ishizaki, T., & Ufhata, M. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)25449-9 · Cited by 332 · see citing works

Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma

Moore, A. R., Ceraudo, E., Sher, J. J., Guan, Y., Shoushtari, A. N., Chang, M. T., Zhang, J. Q., Walczak, E. G., Kazmi, M. A., Taylor, B. S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3549 · Cited by 313 · see citing works

Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells

Marcotte, R., Brown, K. R., Suárez, F., Sayad, A., Karamboulas, K., Krzyzanowski, P. M., Sircoulomb, F., Medrano, M., Fedyshyn, Y., Koh, J. L. Y., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0224 · Cited by 297 · see citing works

Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes.

Gutkind, J. S., Novotny, E. A., Brann, M. R., & Robbins, K. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4703 · Cited by 291 · see citing works

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

Carvajal, R. D., Piperno-Neumann, S., Kapiteijn, E., Chapman, P. B., Frank, S. J., Joshua, A. M., Piulats, J. M., Wolter, P., Cocquyt, V., Chmielowski, B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.1090 · Cited by 272 · see citing works

Cell signalling diversity of the Gqα family of heterotrimeric G proteins

Hubbard, K. B., & Hepler, J. R. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.004 · Cited by 266 · see citing works

An FAK-YAP-mTOR Signaling Axis Regulates Stem Cell-Based Tissue Renewal in Mice

Hu, J. K., Du, W. T., Shelton, S. J., Oldham, M. C., DiPersio, C. M., & Klein, O. D. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.03.023 · Cited by 241 · see citing works

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS

Zuidervaart, W., van Nieuwpoort, F. A., Stark, M. S., Dijkman, R., Packer, L., Borgstein, A. M., Pavey, S. J., van der Velden, P., Out, C. J., Jager, M. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602598 · Cited by 219 · see citing works

αE-catenin inhibits a Src–YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway

Li, P., Silvis, M. R., Honaker, Y., Lien, W.-H., Arron, S. T., & Vasioukhin, V. (2016) · Genes & Development · doi:10.1101/gad.274951.115 · Cited by 180 · see citing works

FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis

Lachowski, D., Cortes, E., Robinson, B., Rice, A., Rombouts, K., & Del Río Hernández, A. E. (2018) · The FASEB Journal · doi:10.1096/fj.201700721r · Cited by 175 · see citing works

Assembly and activation of the Hippo signalome by FAT1 tumor suppressor

Martin, D., Degese, M. S., Vitale-Cross, L., Iglesias-Bartolome, R., Valera, J. L. C., Wang, Z., Feng, X., Yeerna, H., Vadmal, V., Moroishi, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04590-1 · Cited by 174 · see citing works

RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma

Chen, X., Wu, Q., Depeille, P., Chen, P., Thornton, S., Kalirai, H., Coupland, S. E., Roose, J. P., & Bastian, B. C. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.002 · Cited by 172 · see citing works

A Genome-wide RNAi Screen Reveals a Trio-Regulated Rho GTPase Circuitry Transducing Mitogenic Signals Initiated by G Protein-Coupled Receptors

Vaque, J. P., Dorsam, R. T., Feng, X., Iglesias‐Bartolomé, R., Forsthoefel, D. J., Chen, Q., Debant, A., Seeger, M. A., Ksander, B. R., Teramoto, H., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.10.018 · Cited by 163 · see citing works

Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.

Kalinec, G. M., Nazarali, A. J., Hermouet, S., Xu, N., & Gutkind, J. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4687 · Cited by 162 · see citing works

Regulation of G Protein-linked Guanine Nucleotide Exchange Factors for Rho, PDZ-RhoGEF, and LARG by Tyrosine Phosphorylation

Chikumi, H., Fukuhara, S., & Gutkind, J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108504200 · Cited by 162 · see citing works

Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials—TAP and VIP report no. 3

Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.059 · Cited by 145 · see citing works

Harnessing synthetic lethality to predict the response to cancer treatment

Lee, J. S., Das, A., Jerby‐Arnon, L., Arafeh, R., Auslander, N., Davidson, M. A., McGarry, L., James, D. T., Amzallag, A., Park, S. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04647-1 · Cited by 120 · see citing works

Daily shoot extension growth of peach trees growing on rootstocks that reduce scion growth is related to daily dynamics of stem water potential

Basile, B., Marsal, J., & DeJong, T. M. (2003) · Tree Physiology · doi:10.1093/treephys/23.10.695 · Cited by 111 · see citing works

VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION

Groups, T. O. A.-R. M. D. W. P. T. (. A. V. I. P. T. (. S. (2004) · Retina · doi:10.1097/00006982-200402000-00001 · Cited by 94 · see citing works

Thrombin Protease-activated Receptor-1 Signals through Gq- and G13-initiated MAPK Cascades Regulating c-Jun Expression to Induce Cell Transformation

Marinissen, M. J., Servitja, J., Offermanns, S., Simon, M. I., & Gutkind, J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305709200 · Cited by 93 · see citing works

Signaling by Sensory ReceptorsPreprint

Julius, D. J., & Nathans, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005991 · Cited by 86 · see citing works

Divergent Signaling Pathways Link Focal Adhesion Kinase to Mitogen-activated Protein Kinase Cascades

Igishi, T., Fukuhara, S., Patel, V., Katz, B., Yamada, K. M., & Gutkind, J. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30738 · Cited by 86 · see citing works

Cross-talk between calcium and protein kinase A in the regulation of cell migration

Howe, A. K. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.05.006 · Cited by 85 · see citing works

Treatment of choroidal melanoma using photodynamic therapy

BARBAZETTO, I. A., Lee, T. C., Rollins, I. S., Chang, S., & Abramson, D. H. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)02222-5 · Cited by 85 · see citing works

FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth

Tancioni, I., Miller, N. L. G., Uryu, S. A., Lawson, C., Jean, C., Chen, X. L., Kleinschmidt, E. G., & Schlaepfer, D. D. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0551-x · Cited by 72 · see citing works

Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes

Teramoto, H., Malek, R. L., Behbahani, B., Castellone, M. D., Lee, N. H., & Gutkind, J. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206364 · Cited by 54 · see citing works

Activation of transforming G protein-coupled receptors induces rapid tyrosine phosphorylation of cellular proteins, including p125FAK and the p130 v-src Substrate

Gutkind, J. S., & Robbins, K. C. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92363-3 · Cited by 51 · see citing works

Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

Friedman, A. A., Amzallag, A., Pruteanu-Malinici, I., Baniya, S., Cooper, Z. A., Piris, A., Hargreaves, L., Igras, V., Frederick, D. T., Lawrence, D. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140310 · Cited by 45 · see citing works

Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho Kinase Inhibitor Y-27632

Ikeda, F., Terajima, H., Shimahara, Y., Kondo, T., & Yamaoka, Y. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(02)00081-1 · Cited by 26 · see citing works

Photodynamic therapy with verteporfin in subfoveal amelanotic choroidal melanoma (A controlled case).

Souček, P., & Cihelkova, I. (2006) · PubMed · Cited by 25 · see citing works

A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers

Yamaguchi, K., Iglesias‐Bartolomé, R., Wang, Z., Callejas‐Valera, J. L., Amornphimoltham, P., Molinolo, A., Cohen, E. E. W., Califano, J. A., Lippman, S. M., Luo, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7372 · Cited by 22 · see citing works

Oncotargeting G proteins: The Hippo in the room

Feng, X., Chen, Q., & Gutkind, J. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2815 · Cited by 18 · see citing works

Development of a high-throughput method for the determination of ethosuximide in human plasma by liquid chromatography mass spectrometry

Bhatt, M., Shah, S. S., & Shivprakash (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.03.019 · Cited by 18 · see citing works

YAP as oncotarget in uveal melanoma

Yu, F., Zhang, K., & Guan, K. (2014) · Oncoscience · doi:10.18632/oncoscience.57 · Cited by 14 · see citing works

Uveal melanoma

Jager, M. J., Shields, C. L., Cebulla, C. M., Abdel‐Rahman, M. H., Grossniklaus, H. E., Stern, M., Carvajal, R. D., Belfort, R. N., Jia, R., Shields, J. A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0158-0 · Cited by 836 · see citing works

The present and future of the Cancer Dependency Map

Arafeh, R., Shibue, T., Dempster, J. M., Hahn, W. C., & Vazquez, F. (2025) · Nature Reviews Cancer · doi:10.1038/s41568-024-00763-x · Cited by 454 · see citing works

Targeting FAK in anticancer combination therapies

Dawson, J. C., Serrels, A., Stupack, D. G., Schlaepfer, D. D., & Frame, M. C. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00340-6 · Cited by 397 · see citing works

Control of cellular responses to mechanical cues through YAP/TAZ regulation

Dasgupta, I., & McCollum, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007963 · Cited by 360 · see citing works

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer

Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 331 · see citing works

Advances in the clinical management of uveal melanoma

Carvajal, R. D., Sacco, J. J., Jager, M. J., Eschelman, D. J., Bagge, R. O., Harbour, J. W., Chieng, N. D., Patel, S. P., Joshua, A. M., & Piperno-Neumann, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00714-1 · Cited by 289 · see citing works

YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy

Thompson, B. J. (2020) · BioEssays · doi:10.1002/bies.201900162 · Cited by 262 · see citing works

Big data in basic and translational cancer research

Jiang, P., Sinha, S., Aldape, K., Hannenhalli, S., Sahinalp, C., & Ruppin, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00502-0 · Cited by 254 · see citing works

YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches

Piccolo, S., Panciera, T., Contessotto, P., & Cordenonsi, M. (2022) · Nature Cancer · doi:10.1038/s43018-022-00473-z · Cited by 250 · see citing works

Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy

Wu, V. H., Yeerna, H., Nohata, N., Chiou, J., Harismendy, O., Raimondi, F., Inoue, A., Russell, R. B., Tamayo, P., & Gutkind, J. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.005601 · Cited by 177 · see citing works

Static and Dynamic: Evolving Biomaterial Mechanical Properties to Control Cellular Mechanotransduction

Xie, W., Wei, X., Kang, H., Jiang, H., Chu, Z., Lin, Y., Hou, Y., & Wei, Q. (2023) · Advanced Science · doi:10.1002/advs.202204594 · Cited by 176 · see citing works

Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance

Uchihara, T., Miyake, K., Yonemura, A., Komohara, Y., Itoyama, R., Koiwa, M., Yasuda, T., Arima, K., Harada, K., Eto, K., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3803 · Cited by 159 · see citing works

Synthetic lethality-mediated precision oncology via the tumor transcriptome

Lee, J. S., Nair, N. U., Dinstag, G., Chapman, L. M., Chung, Y., Wang, K., Sinha, S., Cha, H., Kim, D., Schperberg, A. V., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.030 · Cited by 154 · see citing works

Molecular profiling of driver events in metastatic uveal melanoma

Karlsson, J. W., Nilsson, L. M., Mitra, S., Alsén, S., Shelke, G. V., Sah, V. R., Forsberg, E. M. V., Stierner, U. K., All‐Eriksson, C., Einarsdottir, B. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15606-0 · Cited by 155 · see citing works

G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers

Arang, N., & Gutkind, J. S. (2020) · FEBS Letters · doi:10.1002/1873-3468.14017 · Cited by 147 · see citing works

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

Haderk, F., Chou, Y., Čech, L., Fernández-Méndez, C., Yu, J. X., Olivas, V. R., Meraz, I. M., Rabago, D. B., Kerr, D. L., Gómez, C. F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47423-0 · Cited by 106 · see citing works

GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma

Silva, P., Fernández‐Díaz, D., Bande, M. F., Pardo, M., Loidi, L., & Blanco‐Teijeiro, M. J. (2022) · Cancers · doi:10.3390/cancers14133066 · Cited by 107 · see citing works

FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials

Mohanty, A. R., Pharaon, R. R., Nam, A., Salgia, S. K., Kulkarni, P., & Massarelli, E. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1740680 · Cited by 101 · see citing works

Photo-tunable hydrogels reveal cellular sensing of rapid rigidity changes through the accumulation of mechanical signaling molecules

Yang, J., Wang, P., Zhang, Y., Zhang, M., Sun, Q., Chen, H., Dong, L., Chu, Z., Xue, B., Hoff, W. D., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.016 · Cited by 95 · see citing works

Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives

Croce, M., Ferrini, S., Pfeffer, U., & Gangemi, R. M. R. (2019) · Cancers · doi:10.3390/cancers11060846 · Cited by 92 · see citing works

Roles and inhibitors of FAK in cancer: current advances and future directions

Hu, H.-H., Wang, S., Shang, H.-L., Lv, H., Chen, B., Gao, S., & Chen, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1274209 · Cited by 91 · see citing works

IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells

Rigiracciolo, D. C., Nohata, N., Lappano, R., Cirillo, F., Talia, M., Scordamaglia, D., Gutkind, J. S., & Maggiolini, M. (2020) · Cells · doi:10.3390/cells9041010 · Cited by 88 · see citing works

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment

Mokhtari, R. B., Ashayeri, N., Baghaie, L., Sambi, M., Satari, K., Baluch, N., Bosykh, D. A., Szewczuk, M. R., & Chakraborty, S. (2023) · Cancers · doi:10.3390/cancers15133468 · Cited by 88 · see citing works

Transcription factors in fibroblast plasticity and CAF heterogeneity

Melchionna, R., Trono, P., Carlo, A. D., Modugno, F. D., & Nisticò, P. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02934-4 · Cited by 87 · see citing works

Sturge-Weber Syndrome: A Review of Pathophysiology, Genetics, Clinical Features, and Current Management Approache

Sánchez‐Espino, L. F., Ivars, M., Antoñanzas, J., & Baselga, E. (2023) · The Application of Clinical Genetics · doi:10.2147/tacg.s363685 · Cited by 85 · see citing works

Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling

Zhang, B., Zhang, Y., Zhang, J., Liu, P., Jiao, B., Wang, Z., & Ren, R. (2021) · Advanced Science · doi:10.1002/advs.202100250 · Cited by 83 · see citing works

Endothelial YAP/TAZ Signaling in Angiogenesis and Tumor Vasculature

Hooglugt, A., van der Stoel, M. M., Boon, R. A., & Huveneers, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.612802 · Cited by 82 · see citing works

Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ -Driven Uveal Melanoma

Paradis, J. S., Acosta, M., Saddawi‐Konefka, R., Kishore, A., Lubrano, S., Gomes, F., Arang, N., Tiago, M., Coma, S., Wu, X., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3363 · Cited by 76 · see citing works

Heterotrimeric Gq proteins as therapeutic targets?

Kostenis, E., Pfeil, E. M., & Annala, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007061 · Cited by 74 · see citing works

Gαs–Protein Kinase A (PKA) Pathway Signalopathies: The Emerging Genetic Landscape and Therapeutic Potential of Human Diseases Driven by Aberrant Gαs-PKA Signaling

Ramms, D. J., Raimondi, F., Arang, N., Herberg, F. W., Taylor, S. S., & Gutkind, J. S. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000269 · Cited by 71 · see citing works

FAK, vinculin, and talin control mechanosensitive YAP nuclear localization

Holland, E. N., Fernández, M., Zhou, D. W., O’Neill, E. B., Woodfolk, A. U., Mora‐Boza, A., Fu, J., Schlaepfer, D. D., & Garcı́a, A. J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122542 · Cited by 71 · see citing works

Functional characterization of uveal melanoma oncogenes

Ma, J., Weng, L., Bastian, B. C., & Chen, X. (2020) · Oncogene · doi:10.1038/s41388-020-01569-5 · Cited by 70 · see citing works

EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1

Ando, T., Arang, N., Wang, Z., Costea, D. E., Feng, X., Goto, Y., Izumi, H., Gilardi, M., Ando, K., & Gutkind, J. S. (2021) · Communications Biology · doi:10.1038/s42003-021-02744-4 · Cited by 67 · see citing works

So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020

Rodrigues, M. J., de Koning, L., Coupland, S. E., Jochemsen, A. G., Marais, R., Stern, M., Valente, A., Barnhill, R. L., Cassoux, N., Evans, A., et al. (2019) · Cancers · doi:10.3390/cancers11071032 · Cited by 67 · see citing works

Functional and clinical characteristics of focal adhesion kinases in cancer progression

Zhang, Z., Li, J., Jiao, S., Han, G., Zhu, J., & Liu, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1040311 · Cited by 62 · see citing works

STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells

Kim, J. W., Berrios, C. J., Kim, M., Schade, A. E., Adelmant, G., Yeerna, H., Damato, E., Iniguez, A. B., Swanson, S. K., Florens, L. A., et al. (2020) · eLife · doi:10.7554/elife.53003 · Cited by 54 · see citing works

Uveal melanoma: progress in molecular biology and therapeutics

Li, Y., Shi, J., Yang, J., Ge, S., Zhang, J., Jia, R., & Fan, X. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920965852 · Cited by 55 · see citing works

A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis

Hoj, J. P., Mayro, B., & Pendergast, A. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.018 · Cited by 54 · see citing works

VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry

Delgado‐Bellido, D., Zamudio-Martínez, E., Fernández‐Cortés, M., Herrera-Campos, A. B., Olmedo-Pelayo, J., Perez, C. J., Expósito, J., de Álava, E., Amaral, A. T., O’Valle, F., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05666-7 · Cited by 51 · see citing works

MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer

Gündoğdu, R., & Hergovich, A. (2019) · Cells · doi:10.3390/cells8060569 · Cited by 51 · see citing works

Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression

Rigiracciolo, D. C., Cirillo, F., Talia, M., Muglia, L., Gutkind, J. S., Maggiolini, M., & Lappano, R. (2021) · Cancers · doi:10.3390/cancers13040645 · Cited by 53 · see citing works

Computational methods, databases and tools for synthetic lethality prediction

Wang, J., Zhang, Q., Han, J., Zhao, Y., Zhao, C., Yan, B., Dai, C., Wu, L., Wen, Y., Zhang, Y., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac106 · Cited by 50 · see citing works

Pathogenesis of Port-Wine Stains: Directions for Future Therapies

Liu, L., Li, X., Zhao, Q., Yang, L., & Jiang, X. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012139 · Cited by 50 · see citing works

Hippo‐Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior

van Soldt, B. J., & Cardoso, W. V. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.371 · Cited by 50 · see citing works

Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK–YAP signaling axis

Goto, Y., Ando, T., Izumi, H., Feng, X., Arang, N., Gilardi, M., Wang, Z., Ando, K., & Gutkind, J. S. (2020) · Oncogene · doi:10.1038/s41388-020-1272-x · Cited by 47 · see citing works

FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma

Lubrano, S., Cervantes‐Villagrana, R. D., Faraji, F., Ramirez, S. I., Sato, K., Adame-Garcia, S. R., Officer, A., Arang, N., Rigiracciolo, D. C., Quiroz, P. Y. A., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.02.001 · Cited by 49 · see citing works

New Insights on the Nuclear Functions and Targeting of FAK in Cancer

Pomella, S., Cassandri, M., Braghini, M. R., Marampon, F., Alisi, A., & Rota, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041998 · Cited by 46 · see citing works

GPR39 Overexpression in OSCC Promotes YAP-Sustained Malignant Progression

Jiang, Y., Li, T., Wu, Y., Xu, H., Xie, C., Dong, Y., Zhong, L., Wang, Z., Zhao, H., Zhou, Y., et al. (2020) · Journal of Dental Research · doi:10.1177/0022034520915877 · Cited by 44 · see citing works

Targeting primary and metastatic uveal melanoma with a G protein inhibitor

Onken, M. D., Makepeace, C. M., Kaltenbronn, K. M., Choi, J., Hernandez-Aya, L. F., Weilbaecher, K. N., Piggott, K., Rao, P. K., Yuede, C. M., Dixon, A. J., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100403 · Cited by 44 · see citing works

Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers

Pathria, G., & Ronai, Z. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.009 · Cited by 42 · see citing works

PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma

de Koning, L., Decaudin, D., Botty, R. E., Nicolas, A., Carita, G., Schuller, M., Ouine, B., Cartier, A., Naguez, A., Fleury, J., et al. (2019) · Cancers · doi:10.3390/cancers11060751 · Cited by 41 · see citing works

Focal adhesion kinase (FAK) inhibitor‐defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K/AKT axis and downstream molecular network

Zhang, L., Zhao, D., Wang, Y., Zhang, W., Zhang, J., Fan, J., Zhan, Q., & Chen, J. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23273 · Cited by 38 · see citing works

Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology

Vivet-Noguer, R., Tarin, M., Roman‐Roman, S., & Alsafadi, S. (2019) · Cancers · doi:10.3390/cancers11071019 · Cited by 40 · see citing works

LACTB suppresses melanoma progression by attenuating PP1A and YAP interaction

Ma, Y., Wang, L., He, F., Yang, J., Ding, Y., Ge, S., Fan, X., Zhou, Y., Xu, X., & Jia, R. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.022 · Cited by 39 · see citing works

Context-dependent transcriptional regulations of YAP/TAZ in cancer

Guo, Y., Luo, J., Zou, H., Liu, C., Deng, L., & Li, P. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.12.019 · Cited by 39 · see citing works

Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer

Faraji, F., Ramirez, S. I., Quiroz, P. Y. A., Mendez-Molina, A. N., & Gutkind, J. S. (2022) · Cells · doi:10.3390/cells11081370 · Cited by 40 · see citing works

Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes‐Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans

Wang, H., Song, X., Liao, H., Wang, P., Zhang, Y., Che, L., Zhang, J., Zhou, Y., Cigliano, A., Ament, C. E., et al. (2020) · Hepatology · doi:10.1002/hep.31692 · Cited by 37 · see citing works

Long noncoding RNA H19 regulates the therapeutic efficacy of mesenchymal stem cells in rats with severe acute pancreatitis by sponging miR-138-5p and miR-141-3p

Song, G., Zhou, J., Song, R., Liu, D., Yu, W., Xie, W., Ma, Z., Gong, J., Meng, H., Yang, T., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01940-z · Cited by 36 · see citing works

Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma

Piaggio, F., Tozzo, V., Bernardi, C., Croce, M., Puzone, R., Viaggi, S., Patrone, S., Barla, A., Coviello, D. A., Jager, M. J., et al. (2019) · Cancers · doi:10.3390/cancers11111688 · Cited by 34 · see citing works

Multi-Functional Regulation by YAP/TAZ Signaling Networks in Tumor Progression and Metastasis

Thrash, H. L., & Pendergast, A. M. (2023) · Cancers · doi:10.3390/cancers15194701 · Cited by 33 · see citing works

G protein‐coupled receptors can control the Hippo/YAP pathway through Gq signaling

Zindel, D., Mensat, P., Vol, C., Homayed, Z., Charrier‐Savournin, F., Trinquet, E., Banères, J., Pin, J., Pannequin, J., Roux, T., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002159r · Cited by 33 · see citing works

The future of targeted kinase inhibitors in melanoma

Caksa, S., Baqai, U., & Aplin, A. E. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108200 · Cited by 33 · see citing works

FACEts of mechanical regulation in the morphogenesis of craniofacial structures

Du, W. T., Bhojwani, A., & Hu, J. K. (2021) · International Journal of Oral Science · doi:10.1038/s41368-020-00110-4 · Cited by 33 · see citing works

Genetic drivers of non‐cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape

Vergara, I. A., Wilmott, J. S., Long, G. V., & Scolyer, R. A. (2021) · Experimental Dermatology · doi:10.1111/exd.14287 · Cited by 33 · see citing works

MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ

Schrenk, S., Bischoff, L. J., Goines, J., Cai, Y., Vemaraju, S., Odaka, Y., Good, S., Palumbo, J. S., Szabo, S., Reynaud, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37516-7 · Cited by 32 · see citing works

Targeting sulfation-dependent mechanoreciprocity between matrix and osteoblasts to mitigate bone loss

Zheng, C., Liu, H., Zhao, P., Lu, W., Song, S., He, T., Fan, J., Wang, D., Yang, P., Jie, Q., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg3983 · Cited by 29 · see citing works

Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma

Lamhamedi-Cherradi, S.-E., Mohiuddin, S., Mishra, D. K., Krishnan, S., Velasco, A. R., Vetter, A. M., Pence, K. A., McCall, D. C., Truong, D. D., Cuglievan, B., et al. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-020-00281-6 · Cited by 30 · see citing works

Genetic Landscape and Emerging Therapies in Uveal Melanoma

Seedor, R. S., Orloff, M. M., & Sato, T. (2021) · Cancers · doi:10.3390/cancers13215503 · Cited by 31 · see citing works

YAP and TAZ: Monocorial and bicorial transcriptional co-activators in human cancers

Sardo, F. L., Canu, V., Maugeri‐Saccà, M., Strano, S., & Blandino, G. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188756 · Cited by 30 · see citing works

Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment

Larribère, L., & Utikal, J. S. (2020) · Cancers · doi:10.3390/cancers12061524 · Cited by 29 · see citing works

Recent Advances in Molecular and Genetic Research on Uveal Melanoma

Fuentes-Rodriguez, A., Mitchell, A., Guérin, S. L., & Landreville, S. (2024) · Cells · doi:10.3390/cells13121023 · Cited by 28 · see citing works

Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression

Zhou, R., Wang, H., Zhang, G., Liu, Y., Liu, X., Li, Z., Shi, G., Yuan, J., Qu, C., Li, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64426-7 · Cited by 28 · see citing works

Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma

Decaudin, D., Frisch-Dit-Leitz, E., Némati, F., Tarin, M., Naguez, A., Zerara, M., Marande, B., Vivet-Noguer, R., Halilovic, E., Fabre, C., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.12.012 · Cited by 28 · see citing works

Dual roles of FAK in tumor angiogenesis: A review focused on pericyte FAK

Zhang, J., Li, W., Wang, W., Chen, Q., Xu, Z., Deng, M., Zhou, L., & He, G. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175694 · Cited by 28 · see citing works

Capillary malformations

Hammill, A. M., & Boscolo, E. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172842 · Cited by 27 · see citing works

Role of Hippo-YAP1/TAZ pathway and its crosstalk in cardiac biology

Chen, X., Yuan, W., Li, Y., Luo, J., & Hou, N. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47142 · Cited by 27 · see citing works

Targeting Oncogenic Gαq/11 in Uveal Melanoma

Lapadula, D., & Benovic, J. (2021) · Cancers · doi:10.3390/cancers13246195 · Cited by 27 · see citing works

PI3K/Akt/YAP signaling promotes migration and invasion of DLD‑1 colorectal cancer cells

Takeda, T., Yamamoto, Y., Tsubaki, M., Matsuda, T., Kimura, A., Shimo, N., & Nishida, S. (2022) · Oncology Letters · doi:10.3892/ol.2022.13226 · Cited by 27 · see citing works

GNAQ mutations drive port wine birthmark-associated Sturge-Weber syndrome: A review of pathobiology, therapies, and current models

Trigt, W. K. V., Kelly, K. M., & Hughes, C. C. W. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.1006027 · Cited by 29 · see citing works

Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a

Anbunathan, H., Verstraten, R., Singh, A. D., Harbour, J. W., & Bowcock, A. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3052 · Cited by 26 · see citing works

YAP Activity is Not Associated with Survival of Uveal Melanoma Patients and Cell Lines

Kim, Y. J., Lee, S. C., Kim, S. E., Kim, S. K., Kim, S. K., & Lee, C. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-63391-z · Cited by 25 · see citing works

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma

Arang, N., Lubrano, S., Ceribelli, M., Rigiracciolo, D. C., Saddawi‐Konefka, R., Faraji, F., Ramirez, S. I., Kim, D., Tosto, F. A., Stevenson, E. J., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101244 · Cited by 26 · see citing works

MITF deficiency accelerates GNAQ-driven uveal melanoma

Phelps, G. B., Hagen, H. R., Amsterdam, A., & Lees, J. A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107006119 · Cited by 24 · see citing works

Nociceptive adenosine A2A receptor on trigeminal nerves orchestrates CGRP release to regulate the progression of oral squamous cell carcinoma

Jiang, L., Zhou, Y., Tang, S., Yang, D., Zhang, Y., Zhang, J., Yang, F., Zhou, T., Xia, X., Chen, Q., et al. (2024) · International Journal of Oral Science · doi:10.1038/s41368-024-00308-w · Cited by 23 · see citing works

Synergic Interactions Between Hepatic Stellate Cells and Uveal Melanoma in Metastatic Growth

Piquet, L., Dewit, L., Schoonjans, N., Millet, M., Bérubé, J., Gerges, P. R. A., Bordeleau, F., & Landreville, S. (2019) · Cancers · doi:10.3390/cancers11081043 · Cited by 23 · see citing works

State-of-the-art in Metastatic Uveal Melanoma Treatment: A 2025 Update

Ziogas, D. C., Foteinou, D., Theocharopoulos, C., Martinos, A., Petsiou, D., Anastasopoulou, A. N., & Gogas, H. J. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01684-0 · Cited by 22 · see citing works

Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer

Peng, K., Zhang, F., Wang, Y., Sahgal, P., Li, T., Zhou, J. R., Liang, X., Zhang, Y., Sethi, N. S., Liu, T., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1609 · Cited by 22 · see citing works

New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma

Wei, A. Z., Maniar, A. B., & Carvajal, R. D. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00443-8 · Cited by 20 · see citing works

Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer

Cervantes‐Villagrana, R. D., García‐Jiménez, I., & Vázquez‐Prado, J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110749 · Cited by 20 · see citing works

Focal adhesion kinase/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis

Chen, J., Zhang, J., Zhu, Y., Zhu, Y., Pang, J., Wu, Q., Wang, Y., & Zhan, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02395-5 · Cited by 19 · see citing works

Uveal melanoma–associated mutations in PLCβ4 are constitutively activating and promote melanocyte proliferation and tumorigenesis

Phan, H. T. N., Kim, N. H., Wei, W., Tall, G. G., & Smrcka, A. V. (2021) · Science Signaling · doi:10.1126/scisignal.abj4243 · Cited by 19 · see citing works

Catalytic site mutations confer multiple states of G protein activation

Hewitt, N., Ma, N., Arang, N., Martin, S. A., Prakash, A., DiBerto, J. F., Knight, K. M., Ghosh, S., Olsen, R. H. J., Roth, B. L., et al. (2023) · Science Signaling · doi:10.1126/scisignal.abq7842 · Cited by 19 · see citing works

Uveal melanoma: Recent advances in immunotherapy

Sorrentino, F. S., Rosa, F. D., Terlizzi, P. D., Toneatto, G., Gabai, A., Finocchio, L., Salati, C., Spadea, L., & Zeppieri, M. (2024) · World Journal of Clinical Oncology · doi:10.5306/wjco.v15.i1.23 · Cited by 19 · see citing works

Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options

Strepkos, D., Markouli, M., Papavassiliou, K. A., Papavassiliou, A. G., & Piperi, C. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12762 · Cited by 19 · see citing works

Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ–focal adhesion kinase signaling circuitry

Arang, N., Lubrano, S., Rigiracciolo, D. C., Nachmanson, D., Lippman, S. M., Mali, P., Harismendy, O., & Gutkind, J. S. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102866 · Cited by 18 · see citing works

Circ_UTRN ameliorates caerulein-induced acute pancreatitis in vitro via reducing inflammation and promoting apoptosis through miR-320-3p/PTK2 axis

Sun, Q., Liang, R., Li, M., & Zhou, H. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab161 · Cited by 18 · see citing works

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

Piperno-Neumann, S., Piulats, J. M., Goebeler, M., Galloway, I., Lugowska, I. A., Becker, J. C., Vihinen, P., Calster, J. V., Hadjistilianou, T., Proença, R. D., et al. (2019) · Cancers · doi:10.3390/cancers11060817 · Cited by 18 · see citing works

G protein-coupled receptors as promising targets in cancer

Almeria, C. V. P., Setiawan, I. M., Siderius, M. H., & Smit, M. J. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.10.005 · Cited by 17 · see citing works

Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations

Liu, X., Run‐hua, Z., Pan, J., Li, Z., Yu, L., & Li, Y. (2024) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13161 · Cited by 18 · see citing works

A Review of MicroRNA in Uveal Melanoma

Li, Y. F., Dong, L., Li, Y., & Wei, W. B. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s253946 · Cited by 17 · see citing works

The GNAQ-oncogenic signaling network: Targeting FAK and its synthetic lethal interactome as a precision therapeutic approach against uveal melanoma

Arang, N. (2022) · eScholarship (California Digital Library)

Abstract IA08: Regulation of YAP by tyrosine phosphorylation of core Hippo pathway components: Lessons learned from the GNAQ oncogene and FAK

Gutkind, J. S. (2020) · Molecular Cancer Research · doi:10.1158/1557-3125.hippo19-ia08

Abstract 6406: FAK and MEK co-targeting: A new multimodal precision therapy for GNAQ-driven uveal melanoma

Paradis, J. S., Acosta, M., Arang, N., Saddawi‐Konefka, R., Kishore, A., Sugase, T., Feng, X., Wood, K. C., Coma, S., Terai, M., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-6406

FAK Is a Critical Mediator of GNAQ-Driven Uveal Melanoma

(2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2019-024

Identifying novel molecular vulnerabilities to PTK2/FAK inhibition in G α q‐driven uveal melanoma using a kinome‐wide CRISPR/Cas9 screen

Kishore, A., Feng, X., Arang, N., Wu, X., Pachter, J. A., Schlaepfer, D. D., Tamayo, P., Cheng, Q., & Gutkind, J. S. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.647.15 · Cited by 1 · see citing works